PARP1 and atrial fibrillation: Another promising therapeutic option to prevent the vicious cycle of “oxidative DNA damage—excessive PARP1 activation and NAD+ depletion” in AF is through exogenous replenishment of NAD+ and/or its various forms of precursors [26].